Literature DB >> 13040333

The anticoagulant effect of phenylindanedione in thromboembolic disorders.

K W G BROWN, R L MACMILLAN.   

Abstract

Entities:  

Keywords:  ANTICOAGULANTS/therapeutic use; PHENYLINDANEDIONE/therapeutic use; PROTHROMBIN TIME/effect of drugs on; THROMBOEMBOLISM/therapy; VITAMIN K/therapeutic use

Mesh：

Substances：

Year:  1953        PMID： 13040333     DOI： 10.1097/00000441-195305000-00005

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  2 in total

1.  Clinical experience with phenylindanedione (danilone) with special reference to dosage.

Authors:  R E BEAMISH; S A CARTER
Journal:  Can Med Assoc J       Date:  1956-01-01       Impact factor: 8.262

2.  AGRANULOCYTOSIS IN TWO PATIENTS RECEIVING PHENYLINDANEDIONE.

Authors:  R L Macmillan; K W Brown
Journal:  Can Med Assoc J       Date:  1953-09       Impact factor: 8.262
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.